Medical Device Industry News | BioSpace
This announcement summarizes Bioretec Ltd's business review for January-March 2024.
INVO Bioscience, Inc. announced financial results for the first quarter of 2024 and provided a business update.
Avinger, Inc., a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, reported results for the first quarter ended March 31, 2024.
CooperCompanies, a leading global medical device company, will participate in the Jefferies Global Healthcare Conference on Wednesday, June 6, 2024.
Aethlon Medical, Inc. announced the pricing of a public offering of an aggregate of 8,100,000 shares of its common stock, Class A warrants to purchase up to 8,100,000 shares of common stock, and Class B warrants to purchase up to 8,100,000 shares of common stock, at a combined public offering price of $0.58 per share and accompanying warrants.
Atraverse Medical, a San Diego-based medical device company, today announces the FDA clearance of its HOTWIRE™ radiofrequency (RF) guidewire, a novel device that enables zero exchange left-heart access while also acting as a rail for catheter-based therapy systems.
Створіть власну стрічку новин
Готові спробувати?
Спробуйте протягом 14 днів. Платіжна картка не потрібна.